447 related articles for article (PubMed ID: 19470010)
21. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
[TBL] [Abstract][Full Text] [Related]
23. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
24. N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
Berg T; Zdunek D; Stalke J; Dupke S; Baumgarten A; Carganico A; Hess G
Eur J Med Res; 2007 Apr; 12(4):152-60. PubMed ID: 17509959
[TBL] [Abstract][Full Text] [Related]
25. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
Grasso S; Leone A; De Michele M; Anaclerio R; Cafarelli A; Ancona G; Stripoli T; Bruno F; Pugliese P; Dambrosio M; Dalfino L; Di Serio F; Fiore T
Crit Care Med; 2007 Jan; 35(1):96-105. PubMed ID: 17095948
[TBL] [Abstract][Full Text] [Related]
26. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
[TBL] [Abstract][Full Text] [Related]
27. Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study.
Baggish AL; van Kimmenade R; Bayes-Genis A; Davis M; Lainchbury JG; Frampton C; Pinto Y; Richards MA; Januzzi JL
Clin Chim Acta; 2007 Jun; 381(2):145-50. PubMed ID: 17445789
[TBL] [Abstract][Full Text] [Related]
28. Plasma N-terminal prohormone brain natriuretic peptide as a marker for postoperative cardiac events in high-risk patients undergoing noncardiac surgery.
Schutt RC; Cevik C; Phy MP
Am J Cardiol; 2009 Jul; 104(1):137-40. PubMed ID: 19576335
[TBL] [Abstract][Full Text] [Related]
29. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
30. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
[TBL] [Abstract][Full Text] [Related]
31. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
[TBL] [Abstract][Full Text] [Related]
32. NT-proBNP as a means of triage for the risk of hospitalisation in primary care.
Adlbrecht C; Neuhold S; Hülsmann M; Strunk G; Ehmsen U; Scholten C; Maurer G; Pacher R
Eur J Prev Cardiol; 2012 Feb; 19(1):55-61. PubMed ID: 21450621
[TBL] [Abstract][Full Text] [Related]
33. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
Dini FL; Fontanive P; Conti U; Andreini D; Cabani E; De Tommasi SM
Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
[TBL] [Abstract][Full Text] [Related]
34. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
[TBL] [Abstract][Full Text] [Related]
35. The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
West MJ; Nestel PJ; Kirby AC; Schnabel R; Sullivan D; Simes RJ; Pollicino C; Lubos E; Münzel TF; White HD; Tonkin AM; Bickel C; Tiret L; Blankenberg S;
Eur Heart J; 2008 Apr; 29(7):923-31. PubMed ID: 18296678
[TBL] [Abstract][Full Text] [Related]
36. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
[TBL] [Abstract][Full Text] [Related]
37. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
[TBL] [Abstract][Full Text] [Related]
38. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men.
Laukkanen JA; Kurl S; Ala-Kopsala M; Vuolteenaho O; Ruskoaho H; Nyyssönen K; Salonen JT
Eur Heart J; 2006 May; 27(10):1230-7. PubMed ID: 16621869
[TBL] [Abstract][Full Text] [Related]
39. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
Korse CM; Taal BG; de Groot CA; Bakker RH; Bonfrer JM
J Clin Oncol; 2009 Sep; 27(26):4293-9. PubMed ID: 19667278
[TBL] [Abstract][Full Text] [Related]
40. Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure.
Alehagen U; Dahlström U
Int J Cardiol; 2009 Apr; 133(2):233-40. PubMed ID: 18407361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
